Recently, a study using the novel small molecule inhibitor for ALDH1A, CM37, demonstrated that ALDH1 inhibition in ovarian cancer cell lines caused a significant increase in reactive oxygen species (ROS) 18. The gene discussed is ALDH1A1; the disease is ovarian cancer.